EP2720696
COMBINATION OF PANOBINOSTAT AND RUXOLITINIB IN THE TREATMENT OF CANCER SUCH AS A MYELOPROLIFERATIVE NEOPLASM
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.6.2012EP published:
25.5.2016EP application number:
12730099.4
EPO information:
European Patent Register
Max expiry date:
12.6.2032
Title:
COMBINATION OF PANOBINOSTAT AND RUXOLITINIB IN THE TREATMENT OF CANCER SUCH AS A MYELOPROLIFERATIVE NEOPLASM
Timeline
Today
13.6.2012EP application
25.5.2016EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
BAFFERT, FabienneAddress:
Basel, CH
Name:
RADIMERSKI, ThomasAddress:
Basel, CH
Name:
GADBAW, BrianAddress:
East Hanover, New Jersey, US
Priority
Number:
201161496750 PDate:
14.6.2011Country:
US
Number:
201161568717 PDate:
9.12.2011Country:
US
Classification
Categories:
A61K 31/4045, A61K 31/519